Hexagon Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22	Closed	-$14K	–	1342
2025 Q1	$14K	Sell	22 -7	-24%	-$4.82K	﹤0.01%	869
2024 Q4	$20.7K	Buy	29 +8	+38%	+$6.71K	﹤0.01%	774
2024 Q3	$22.1K	Buy	21 +8	+62%	+$8.9K	﹤0.01%	683
2024 Q2	$13.7K	Sell	13 -8	-38%	-$7.75K	﹤0.01%	792
2024 Q1	$20.2K	Buy	21 +11	+110%	+$10.5K	﹤0.01%	673
2023 Q4	$8.78K	Hold	10	–	–	﹤0.01%	854
2023 Q3	$8.23K	Sell	10 -3	-23%	-$2.36K	﹤0.01%	794
2023 Q2	$9.34K	Hold	13	–	–	﹤0.01%	763
2023 Q1	$10.7K	Sell	13 -2	-13%	-$1.51K	﹤0.01%	716
2022 Q4	$10.8K	Sell	15 -12	-44%	-$8.85K	﹤0.01%	710
2022 Q3	$19K	Buy	27 +24	+800%	+$15.1K	0.01%	607
2022 Q2	$2K	Buy	+3	New	+$1.95K	﹤0.01%	996
2020 Q4	–	Sell	-50	Closed	-$27K	–	744
2020 Q3	$27K	Buy	+50	New	+$30.3K	0.01%	319